286 related articles for article (PubMed ID: 32207326)
1. Global hotspots and future prospects of chimeric antigen receptor T-cell therapy in cancer research: a bibliometric analysis.
Liu M; Gao Y; Yuan Y; Shi S; Yang K; Wu J; Zhang J; Tian J
Future Oncol; 2020 Apr; 16(10):597-612. PubMed ID: 32207326
[No Abstract] [Full Text] [Related]
2. Current status and future prospects of chimeric antigen receptor-T cell therapy in lymphoma research: A bibliometric analysis.
Ou L; Su C; Liang L; Duan Q; Li Y; Zang H; He Y; Zeng R; Li Y; Zhou H; Xiao L
Hum Vaccin Immunother; 2023 Dec; 19(3):2267865. PubMed ID: 37846106
[TBL] [Abstract][Full Text] [Related]
3. A bibliometric and scientific knowledge-map study of the chimeric antigen receptor (CAR) natural killer (NK) cell-related research from 2010 to 2022.
Zhang J; Chen P; Miao L
Front Immunol; 2022; 13():969196. PubMed ID: 36032149
[TBL] [Abstract][Full Text] [Related]
4. A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021.
Miao L; Zhang J; Zhang Z; Wang S; Tang F; Teng M; Li Y
Front Immunol; 2022; 13():840956. PubMed ID: 35371087
[TBL] [Abstract][Full Text] [Related]
5. Bibliometric analysis of research trends and active research areas in chimeric antigen receptor T cell therapy for hematologic malignancies.
Zhang G; Deng L; Lu H; Zhang W
Int J Clin Pharm; 2024 Feb; 46(1):186-194. PubMed ID: 38087131
[TBL] [Abstract][Full Text] [Related]
6. Bibliometric Analysis of Chimeric Antigen Receptor-Based Immunotherapy in Cancers From 2001 to 2021.
Ou Z; Qiu L; Rong H; Li B; Ren S; Kuang S; Lan T; Lin H; Li Q; Wu F; Cai T; Yan L; Ye Y; Fan S; Li J
Front Immunol; 2022; 13():822004. PubMed ID: 35432345
[TBL] [Abstract][Full Text] [Related]
7. Global research trends in immunotherapy for glioma: a comprehensive visualization and bibliometric analysis.
Zhang HY; Yu HY; Zhao GX; Jiang XZ; Gao G; Wei BJ
Front Endocrinol (Lausanne); 2023; 14():1273634. PubMed ID: 37867521
[TBL] [Abstract][Full Text] [Related]
8. Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer.
Gao Y; Shi S; Ma W; Chen J; Cai Y; Ge L; Li L; Wu J; Tian J
Int Immunopharmacol; 2019 Jul; 72():374-384. PubMed ID: 31030093
[TBL] [Abstract][Full Text] [Related]
9. Chimeric antigen receptor-engineered T-cell therapy for liver cancer.
Chen Y; E CY; Gong ZW; Liu S; Wang ZX; Yang YS; Zhang XW
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):301-309. PubMed ID: 29861325
[TBL] [Abstract][Full Text] [Related]
10. A bibliometric and knowledge-map study of CAR-T cell-related cytokine release syndrome (CRS) from 2012 to 2023.
Li H; Huang Q; Zhang Y
Hum Vaccin Immunother; 2023 Dec; 19(3):2291900. PubMed ID: 38112002
[TBL] [Abstract][Full Text] [Related]
11. The research status and prospects of MUC1 in immunology.
Long L; Huang X; Yu S; Fan J; Li X; Xu R; Zhang X; Huang H
Hum Vaccin Immunother; 2023 Dec; 19(1):2172278. PubMed ID: 36744407
[TBL] [Abstract][Full Text] [Related]
12. The 100 Most Influential Studies in Chimeric Antigen Receptor T-Cell: A Bibliometric Analysis.
Seo B; Kim S; Kim J
Front Med Technol; 2020; 2():3. PubMed ID: 35047874
[No Abstract] [Full Text] [Related]
13. Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspective.
Han C; Kwon BS
Immunotherapy; 2018 Mar; 10(3):221-234. PubMed ID: 29370727
[TBL] [Abstract][Full Text] [Related]
14. Research Trends and Hotspots Analysis Related to Monocarboxylate Transporter 1: A Study Based on Bibliometric Analysis.
He S; Zhao Y; Fan Y; Zhao X; Yu J; Xie J; Wang C; Su J
Int J Environ Res Public Health; 2019 Mar; 16(7):. PubMed ID: 30934693
[No Abstract] [Full Text] [Related]
15. Preclinical Models in Chimeric Antigen Receptor-Engineered T-Cell Therapy.
Siegler EL; Wang P
Hum Gene Ther; 2018 May; 29(5):534-546. PubMed ID: 29390873
[TBL] [Abstract][Full Text] [Related]
16. Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells.
Elahi R; Khosh E; Tahmasebi S; Esmaeilzadeh A
Front Immunol; 2018; 9():1717. PubMed ID: 30108584
[TBL] [Abstract][Full Text] [Related]
17. Global research trends on B7-H3 for cancer immunotherapy: A bibliometric analysis (2012-2022).
Huang X; Guo J; Wang S; Lin Z; Zhao S; Li W; Wang Y; Zhu C; Lv J; Qiu W
Hum Vaccin Immunother; 2023 Aug; 19(2):2246498. PubMed ID: 37635349
[TBL] [Abstract][Full Text] [Related]
18. Severe fever with thrombocytopenia syndrome virus trends and hotspots in clinical research: A bibliometric analysis of global research.
Zhang Z; Tan J; Jin W; Qian H; Wang L; Zhou H; Yuan Y; Wu X
Front Public Health; 2023; 11():1120462. PubMed ID: 36817929
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 genome editing: Fueling the revolution in cancer immunotherapy.
Liu X; Zhao Y
Curr Res Transl Med; 2018 May; 66(2):39-42. PubMed ID: 29691200
[TBL] [Abstract][Full Text] [Related]
20. Global research trends in spinal ultrasound: a systematic bibliometric analysis.
Zhai X; Cui J; Shao J; Wang Q; Chen X; Wei X; Zhou X; Chen Z; Bai Y; Li M
BMJ Open; 2017 Oct; 7(10):e015317. PubMed ID: 29061600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
